Reports Q2 revenue $0, consensus $280K. As of June 30, Lipocine had $25.8M of unrestricted cash, cash equivalents and marketable investment securities compared to $32.5M at December 31, 2022.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on LPCN:
